Bill Brown

CTAM is an active manager that performs in-house research, strategic analysis, and risk modeling to reach decisions. The firm conducts company visits as one of the key areas of their research. The firm is a self-described 'multi-boutique' that is organized into small teams that follow specific products. They offer funds investing in a range of assets such as real estate, equities, fixed-income, and multi-manager. CTAM provides a variety of alternative, ethical, lifestyle, and investment trust strategies.

Bluehone seeks to provide shareholders with medium- to long-term capital growth by investing in a portfolio of predominantly UK small companies, particularly those listed on AIM, which have the potential to increase their value either by delivering on a growth business plan or by structural, corporate or shareholder change. The firm believes that small companies display strong venture capital characteristics and the team adopts a venture capital approach of seeking to understand the business plan and prospects of a company with a view to formulating what a business could be worth if the business plan is successfully implemented. If the risk reward equation is attractive, Bluehone becomes a supportive and active shareholder, while also considering appropriate exit strategies to realize value for clients.

Operates as a holding company which engages in the development and exploitation of biomaterials and medical devices

Acts as Closed-End Investment Fund/Investment Trust

Functions as a College/University

Manufactures medical devices

Operates as a professional membership organization

Provides fund management services

Operates as an investment management holding company